Details for Patent: 5,872,130
✉ Email this page to a colleague
Title: | Quinoline type mevalonoactones |
Abstract: | Described herein are mevalonolactone derivatives having a quinoline ring of formula (I) ##STR1## wherein the R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Y and Z variables are described therein. |
Inventor(s): | Fujikawa; Yoshihiro (Funabashi, JP), Suzuki; Mikio (Funabashi, JP), Iwasaki; Hiroshi (Funabashi, JP), Sakashita; Mitsuaki (Shiraoka-machi, JP), Kitahara; Masaki (Shiraoka-machi, JP) |
Assignee: | Nissan Chemical Industries Ltd. (Tokyo, JP) |
Filing Date: | Dec 19, 1990 |
Application Number: | 07/631,092 |
Claims: | 1. A compound of the formula ##STR16## wherein c-Pr is cyclopropyl, and Z is --CH(OH)--CH.sub.2 --CH(OH)--CH.sub.2 --COOH, --CH(OH)--CH.sub.2 -- CH(OH)--CH.sub.2 --COONa, --CH(OH)--CH.sub.2 --CH(OH)--CH.sub.2 --COOR (wherein R is C.sub.1-3 alkyl), or ##STR17## 2. An anti-hyperlipidemia agent containing the compound of the formula A as defined in claim 1. 3. An anti-hyperlipoproteinemia agent containing the compound of the formula A as defined in claim 1. 4. An anti-atherosclerosis agent containing the compound of the formula A as defined in claim 1. 5. A method for reducing hyperlipidemia, hyperlipoproteinemia or atherosclerosis, which comprises administering an effective amount of the compound of formula A as defined in claim 1. |